GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors

Life Sciences

Volumn 92, Issue 8-9, 2013, Pages 453-457

  Zhao, Pingwei ^a   Abood, Mary E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid; G protein coupled receptor; GPR35; GPR55; Lysophospholipid

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2 ARACHIDONOYLYSOPHOSPHATIDIC ACID; CANNABINOID RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 35; G PROTEIN COUPLED RECEPTOR 55; KYNURENIC ACID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLINOSITOL; LYSOPHOSPHOLIPID RECEPTOR; MONOACYLGLYCEROL; PHOSPHOLIPASE C; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG DEPENDENCE; HUMAN; METABOLIC DISORDER; NEOPLASM; PAIN; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; CANNABINOIDS; GENE EXPRESSION; HUMANS; LIGANDS; RECEPTORS, CANNABINOID; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHOLIPID;

EID: 84874651766     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.06.039     Document Type: Conference Paper

References (53)

1. C. Andradas, M.M. Caffarel, E. Perez-Gomez, M. Salazar, M. Lorente, and G. Velasco The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK Oncogene 30 2011 245 252
2. K. Bandoh, J. Aoki, A. Taira, M. Tsujimoto, H. Arai, and K. Inoue Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors FEBS Lett 478 2000 159 165 (Pubitemid 30462278)
3. M.C. Barth, N. Ahluwalia, T.J. Anderson, G.J. Hardy, S. Sinha, and J.A. Alvarez-Cardona Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions J Biol Chem 284 2009 19189 19195
4. + channels in endothelial cells Pflugers Arch 461 2011 177 189
5. A.J. Brown, D.A. Daniels, M. Kassim, S. Brown, C.P. Haslam, and V.R. Terrell Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist J Pharmacol Exp Ther 337 2011 236 246
6. C. Cosi, G. Mannaioni, A. Cozzi, V. Carla, M. Sili, and L. Cavone G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast Neuropharmacology 60 2011 1227 1231
7. H. Deng, H. Hu, and Y. Fang Tyrphostin analogs are GPR35 agonists FEBS Lett 585 2011 1957 1962
8. H. Deng, H. Hu, M. He, J. Hu, W. Niu, and A.M. Ferrie Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2- carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists J Med Chem 54 2011 7385 7396
9. L.A. Ford, A.J. Roelofs, S. Anavi-Goffer, L. Mowat, D.G. Simpson, and A.J. Irving A role for l-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells Br J Pharmacol 160 2010 762 771
10. 2 + signaling and NFAT activation FASEB J 23 2009 183 193
11. C.M. Henstridge, N.A. Balenga, R. Schroder, J.K. Kargl, W. Platzer, and L. Martini GPR55 ligands promote receptor coupling to multiple signalling pathways Br J Pharmacol 160 2010 604 614
12. C.M. Henstridge, N.A. Balenga, J. Kargl, C. Andradas, A.J. Brown, and A. Irving Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 Mol Endocrinol 25 2011 1835 1848
13. S. Heynen-Genel, R. Dahl, S. Shi, L. Milan, S. Hariharan, and Y. Bravo Screening for selective ligands for gpr55 - agonists 2010
14. S. Heynen-Genel, R. Dahl, S. Shi, L. Milan, S. Hariharan, and E. Sergienko Screening for selective ligands for GPR55 - antagonists 2010
15. S. Heynen-Genel, R. Dahl, S. Shi, M. Sauer, S. Hariharan, and E. Sergienko Antagonists for the orphan receptor GPR35 Probe Reports from the NIH Molecular Libraries Program [Internet] 2010 National Center for Biotechnology Information (US) Bethesda (MD) (2010 Feb 28 [updated 2010 Oct 4])
16. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, and W.A. Devane International union of pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 2002 161 202 (Pubitemid 34575709)
17. L. Huang, J.C. Ramirez, G.A. Frampton, L.E. Golden, M.A. Quinn, and H.Y. Pae Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor Lab Invest 91 2011 1007 1017
18. M. Imielinski, R.N. Baldassano, A. Griffiths, R.K. Russell, V. Annese, and M. Dubinsky Common variants at five new loci associated with early-onset inflammatory bowel disease Nat Genet 41 2009 1335 1340
19. L. Jenkins, E. Alvarez-Curto, K. Campbell, S. de Munnik, M. Canals, and S. Schlyer Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Galpha and beta-arrestin-2 Br J Pharmacol 162 2010 733 748
20. H. Kanoh, T. Iwata, T. Ono, and T. Suzuki Immunological characterization of sn-1,2-diacylglycerol and sn-2-monoacylglycerol kinase from pig brain J Biol Chem 261 1986 5597 5602 (Pubitemid 17204378)
21. A. Kapur, P. Zhao, H. Sharir, Y. Bai, M.G. Caron, and L.S. Barak Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands J Biol Chem 284 2009 29817 29827
22. E. Kotsikorou, K.E. Madrigal, D.P. Hurst, H. Sharir, D.L. Lynch, and S. Heynen-Genel Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands Biochemistry 2011 2011 1
23. C.W. Lee, R. Rivera, S. Gardell, A.E. Dubin, and J. Chun GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 J Biol Chem 281 2006 23589 23597 (Pubitemid 44274133)
24. J. Liu, A. Divoux, J. Sun, J. Zhang, K. Clement, and J.N. Glickman Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice Nat Med 15 2009 940 945
25. G. Milligan Orthologue selectivity and ligand bias: translating the pharmacology of GPR35 Trends Pharmacol Sci 32 2011 317 325
26. K.D. Min, M. Asakura, Y. Liao, K. Nakamaru, H. Okazaki, and T. Takahashi Identification of genes related to heart failure using global gene expression profiling of human failing myocardium Biochem Biophys Res Commun 393 2010 55 60
27. S. Nakane, S. Oka, S. Arai, K. Waku, Y. Ishima, and A. Tokumura 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain Arch Biochem Biophys 402 2002 51 58 (Pubitemid 34848294)
28. K. Noguchi, S. Ishii, and T. Shimizu Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J Biol Chem 278 2003 25600 25606 (Pubitemid 36835313)
29. B.F. O'Dowd, T. Nguyen, A. Marchese, R. Cheng, K.R. Lynch, and H.H. Heng Discovery of three novel G-protein-coupled receptor genes Genomics 47 1998 310 313 (Pubitemid 28086858)
30. H. Ohshiro, H. Tonai-Kachi, and K. Ichikawa GPR35 is a functional receptor in rat dorsal root ganglion neurons Biochem Biophys Res Commun 365 2008 344 348 (Pubitemid 350137295)
31. S. Oka, K. Nakajima, A. Yamashita, S. Kishimoto, and T. Sugiura Identification of GPR55 as a lysophosphatidylinositol receptor Biochem Biophys Res Commun 362 2007 928 934 (Pubitemid 47390663)
32. S. Oka, T. Toshida, K. Maruyama, K. Nakajima, A. Yamashita, and T. Sugiura 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55 J Biochem 145 2009 13 20
33. S. Oka, R. Ota, M. Shima, A. Yamashita, and T. Sugiura GPR35 is a novel lysophosphatidic acid receptor Biochem Biophys Res Commun 395 2010 232 237
34. Y. Okada, Y. Tsuzuki, J. Miyazaki, K. Matsuzaki, R. Hokari, and S. Komoto Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing Gut 55 2006 681 688
35. S. Okumura, H. Baba, T. Kumada, K. Nanmoku, H. Nakajima, and Y. Nakane Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells Cancer Sci 95 2004 131 135 (Pubitemid 38404313)
36. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, and M.R. Elphick International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB Pharmacol Rev 62 2010 588 631
37. R. Pineiro, and M. Falasca Lysophosphatidylinositol signalling: new wine from an old bottle Biochim Biophys Acta 1821 2012 694 705
38. R. Pineiro, T. Maffucci, and M. Falasca The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation Oncogene 30 2011 142 152
39. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol Sci 30 2009 156 163
40. E. Ryberg, N. Larsson, S. Sjogren, S. Hjorth, N.O. Hermansson, and J. Leonova The orphan receptor GPR55 is a novel cannabinoid receptor Br J Pharmacol 152 2007 1092 1101 (Pubitemid 350166046)
41. M. Sawzdargo, T. Nguyen, D.K. Lee, K.R. Lynch, R. Cheng, and H.H. Heng Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain Brain Res Mol Brain Res 64 1999 193 198 (Pubitemid 29052470)
42. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol Ther 126 2010 301 313
43. H. Sharir, L. Console-Bram, C. Mundy, S.M. Popoff, A. Kapur, and M.E. Abood The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55 J Neuroimmune Pharmacol 2012 [Electronic publication ahead of print Mar 28]
44. Y.H. Shim, C.H. Lin, and K.P. Strickland The purification and properties of monoacylglycerol kinase from bovine brain Biochem Cell Biol 67 1989 233 241 (Pubitemid 19174750)
45. L. Sparfel, M.L. Pinel-Marie, M. Boize, S. Koscielny, S. Desmots, and A. Pery Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene Toxicol Sci 114 2010 247 259
46. P.C. Staton, J.P. Hatcher, D.J. Walker, A.D. Morrison, E.M. Shapland, and J.P. Hughes The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain Pain 139 2008 225 236
47. Y.V. Sun, L.F. Bielak, P.A. Peyser, S.T. Turner, P.F. Sheedy II, and E. Boerwinkle Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design Genet Epidemiol 32 2008 350 360 (Pubitemid 351656306)
48. Y. Taniguchi, H. Tonai-Kachi, and K. Shinjo Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35 FEBS Lett 580 2006 5003 5008 (Pubitemid 44332369)
49. J. Wang, N. Simonavicius, X. Wu, G. Swaminath, J. Reagan, and H. Tian Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 J Biol Chem 281 2006 22021 22028 (Pubitemid 44181906)
50. L.S. Whyte, E. Ryberg, N.A. Sims, S.A. Ridge, K. Mackie, and P.J. Greasley The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo Proc Natl Acad Sci U S A 106 2009 16511 16516
51. K. Yanagida, K. Masago, H. Nakanishi, Y. Kihara, F. Hamano, and Y. Tajima Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6 J Biol Chem 284 2009 17731 17741
52. Y. Yang, J.Y. Lu, X. Wu, S. Summer, J. Whoriskey, and C. Saris G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium Pharmacology 86 2010 1 5
53. P. Zhao, H. Sharir, A. Kapur, A. Cowan, E.B. Geller, and M.W. Adler Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and beta-arrestin2 with antinociceptive activity Mol Pharmacol 78 2010 560 568